Position in AURA
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$558,668
New position
Shares Held
83,508
first reported quarter
Ownership
0.081%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 1%
Shared 0%
None 99%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Fisher Asset Management, LLC holds $672,291,918 across 48 Biotechnology names. AURA ranks #47 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,113,568 | $69,820,713 | |
| 2 | CYTK |
Cytokinetics Inc
|
768,264 | $50,636,280 | |
| 3 | RCUS |
Arcus Biosciences, Inc.
|
2,190,404 | $47,312,726 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
2,436,895 | $46,788,384 | |
| 5 | VRDN |
Viridian Therapeutics, Inc.\DE
|
1,768,295 | $34,587,850 | |
| 6 | CLDX |
Celldex Therapeutics, Inc.
|
1,013,648 | $32,152,914 | |
| 7 | CGON |
CG Oncology, Inc.
|
465,033 | $31,473,433 | |
| 8 | IDYA |
IDEAYA Biosciences, Inc.
|
882,699 | $29,411,530 |
All Filings in AURA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $558,668 | 83,508 | Shares | Defined | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||